Quest Diagnostics (DGX): EdgePoint Investment Group Inc. added to its stake +848K shares
EdgePoint Investment Group Inc. added to its stake in Quest Diagnostics, per its Q3 2025 13F.
- 850K
- Shares reported · +848K vs prior quarter
- 1.2%
- Disclosed portfolio weight
- $162M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Nov 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 28, 2025CongressDisclosed purchase of DGX — reported range $1,001 - $15,000
- Jul 24, 2025CongressDisclosed sale of DGX — reported range $1,001 - $15,000
- Sep 23, 2025InsiderOfficer sold ~$5.29M of DGX shares in the open market
- Sep 24, 2025InsiderOfficer sold ~$33K of DGX shares in the open market
- Sep 26, 2025Insider · 1 personInsiders: 2 sales (~$43K)
- Oct 21, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 22, 2025InsiderDirector sold ~$270K of DGX shares in the open market
- Nov 3, 2025CongressDisclosed sale of DGX — reported range $1,001 - $15,000
What came next
- Nov 18, 2025Insider · Their largest sale since 2024Officer sold ~$1.49M of DGX shares in the open market
- Nov 25, 2025Insider · 2 peopleInsiders: 4 sales (~$10.8M)
- Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Feb 10, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Feb 10, 2026InsiderOfficer sold ~$1.16M of DGX shares in the open market
- Feb 13, 2026Insider · 1 personInsiders: 5 sales (~$5.4M)
- Feb 19, 2026Insider · 3 peopleInsiders: 3 sales (~$717K)
- Mar 2, 2026InsiderCEO sold ~$2.13M of DGX shares in the open market
- Mar 3, 2026Insider · 3 peopleInsiders: 3 sales (~$326K)
- Mar 4, 2026InsiderOfficer sold ~$538K of DGX shares in the open market
- Mar 5, 2026Insider · 3 peopleInsiders: 3 sales (~$2.5M)
- Mar 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, the Board of Directors (the “Board”) of Quest Diagnostics Incorporated (the “Company”), after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director.”
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Quest Diagnostics
For Quest Diagnostics, OQRO holds 20 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DGX page.
How this filing works
Explore the data
Common questions
What does this filing report about Quest Diagnostics (DGX) stock?
EdgePoint Investment Group Inc. added to its stake in Quest Diagnostics, per its Q3 2025 13F. Now 850K shares, $162M reported value, 1.2% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Sep 30, 2025. Filed: Nov 14, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Quest Diagnostics recently?
For Quest Diagnostics, OQRO holds 20 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the DGX page.
Does this mean DGX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Quest Diagnostics
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
Everything OQRO holds on this company is on its DGX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data